These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31666283)

  • 1. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
    Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
    Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
    Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double Positivity for HPV DNA/P16
    Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG
    Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.
    Guo M; Khanna A; Wang J; Williams MD; Kalhor N; Gong Y; Xu L; Sturgis EM; Staerkel G
    Arch Pathol Lab Med; 2019 Mar; 143(3):356-361. PubMed ID: 30221979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
    Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients.
    Lu XJD; Liu KYP; Prisman E; Wu J; Zhu YS; Poh C
    Oral Dis; 2023 Mar; 29(2):483-490. PubMed ID: 34129700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains.
    Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N
    Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
    Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
    Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort.
    Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS
    Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus in oropharyngeal squamous cell carcinoma.
    Fauzi FH; Hamzan NI; Rahman NA; Suraiya S; Mohamad S
    J Zhejiang Univ Sci B; 2020 Dec.; 21(12):961-976. PubMed ID: 33843162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
    Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
    Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
    Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
    Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.